human placenta cdna libraries (TaKaRa)
TaKaRa is a verified supplier 
TaKaRa manufactures this product 
93
Structured Review
TaKaRa
human placenta cdna libraries
Human Placenta Cdna Libraries, supplied by TaKaRa, used in various techniques. Bioz Stars score: 93/100, based on 431 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+placenta+cdna+libraries/Human+Placenta+QUICK-Clone+cDNA/pm41086683-39-14-23
Average 93 stars, based on 431 article reviews
Human Placenta Cdna Libraries, supplied by TaKaRa, used in various techniques. Bioz Stars score: 93/100, based on 431 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+placenta+cdna+libraries/Human+Placenta+QUICK-Clone+cDNA/pm41086683-39-14-23
Average 93 stars, based on 431 article reviews
human placenta cdna libraries - by Bioz Stars,
2026-09
93/100 stars
Images
Related Articles
Plasmid Preparation:Article Title: Screening for novel L-type amino acid transporter 1 (SLC7A5) inhibitors using a fluorescent amino acid. Article Snippet: L-type amino acid transporter 1 (LAT1) facilitates the transport of neutral amino acids with bulky side chains, including many essential amino acids that activate the mechanistic target of rapamycin (mTOR), thereby promoting cell proliferation.. Inhibition of LAT1 suppresses abnormal cell growth, such as in cancer and polycystic kidney disease.. Fluorescent probes are essential tools for monitoring transport activity and screening for novel inhibitors. Construct:Article Title: Screening for novel L-type amino acid transporter 1 (SLC7A5) inhibitors using a fluorescent amino acid. Article Snippet: L-type amino acid transporter 1 (LAT1) facilitates the transport of neutral amino acids with bulky side chains, including many essential amino acids that activate the mechanistic target of rapamycin (mTOR), thereby promoting cell proliferation.. Inhibition of LAT1 suppresses abnormal cell growth, such as in cancer and polycystic kidney disease.. Fluorescent probes are essential tools for monitoring transport activity and screening for novel inhibitors. Clone Assay:Article Title: Screening for novel L-type amino acid transporter 1 (SLC7A5) inhibitors using a fluorescent amino acid. Article Snippet: L-type amino acid transporter 1 (LAT1) facilitates the transport of neutral amino acids with bulky side chains, including many essential amino acids that activate the mechanistic target of rapamycin (mTOR), thereby promoting cell proliferation.. Inhibition of LAT1 suppresses abnormal cell growth, such as in cancer and polycystic kidney disease.. Fluorescent probes are essential tools for monitoring transport activity and screening for novel inhibitors. Polymerase Chain Reaction:Article Title: Screening for novel L-type amino acid transporter 1 (SLC7A5) inhibitors using a fluorescent amino acid. Article Snippet: L-type amino acid transporter 1 (LAT1) facilitates the transport of neutral amino acids with bulky side chains, including many essential amino acids that activate the mechanistic target of rapamycin (mTOR), thereby promoting cell proliferation.. Inhibition of LAT1 suppresses abnormal cell growth, such as in cancer and polycystic kidney disease.. Fluorescent probes are essential tools for monitoring transport activity and screening for novel inhibitors. Cloning:Article Title: Screening for novel L-type amino acid transporter 1 (SLC7A5) inhibitors using a fluorescent amino acid. Article Snippet: L-type amino acid transporter 1 (LAT1) facilitates the transport of neutral amino acids with bulky side chains, including many essential amino acids that activate the mechanistic target of rapamycin (mTOR), thereby promoting cell proliferation.. Inhibition of LAT1 suppresses abnormal cell growth, such as in cancer and polycystic kidney disease.. Fluorescent probes are essential tools for monitoring transport activity and screening for novel inhibitors. |